FDA Set to Approve Pfizer COVID-19 Booster for Children as Young as 12
The Food and Drug Administration on Monday is expected to green-light giving Pfizer-BioNTech's COVID-19 vaccine booster to children as young as 12, according to The New York Times. The FDA will endorse giving healthy 12- to 15-year-olds a third dose to bolster their vaccine immunity. That's great for 12-15 year-olds! I'm still 11 and I won't be 12 until May, but by then, the FDA will probably authorize the booster for 5-12 year-olds as well.
Photo Credit: Vlad Chețan